Point72 Hong Kong’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,928
Closed -$463K 615
2024
Q3
$463K Buy
+10,928
New +$463K 0.03% 247
2022
Q4
Sell
-11,734
Closed -$561K 1543
2022
Q3
$561K Buy
11,734
+5,265
+81% +$289K 0.02% 710
2022
Q2
$383K Buy
+6,469
New +$531K 0.01% 794
2022
Q1
Sell
-1,315
Closed -$198K 2317
2021
Q4
$198K Buy
+1,315
New +$177K 0.01% 1016
2021
Q3
Sell
-1,320
Closed -$129K 2436
2021
Q2
$129K Sell
1,320
-724
-35% -$64.6K ﹤0.01% 1260
2021
Q1
$180K Sell
2,044
-12,593
-86% -$1.17M 0.01% 1068
2020
Q4
$1.4M Buy
+14,637
New +$1.51M 0.06% 373
2020
Q2
Sell
-13
Closed -$1K 1425
2020
Q1
$1K Buy
+13
New +$911 ﹤0.01% 880
2019
Q4
Sell
-32
Closed -$2K 1457
2019
Q3
$2K Buy
32
+14
+78% +$894 ﹤0.01% 881
2019
Q2
$1K Sell
18
-255
-93% -$16.5K ﹤0.01% 1058
2019
Q1
$17K Buy
+273
New +$14.3K 0.01% 703
2018
Q4
Sell
-1,765
Closed -$76K 1201
2018
Q3
$76K Buy
1,765
+686
+64% +$24K 0.03% 396
2018
Q2
$24K Buy
+1,079
New +$13.3K 0.01% 553
2016
Q4
Sell
-30
Closed -$2K 1041
2016
Q3
$2K Buy
+30
New +$2.19K ﹤0.01% 710

Other funds holding TNDM

Point72 Hong Kong's TNDM Position: Q4 2024 in Review

Point72 Hong Kong sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 10,928 shares — an estimated $463K sold.

Point72 Hong Kong first reported a position in TNDM in Q3 2016 and held it in 14 quarters. The position peaked at $1.4M in Q4 2020. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

  • Point72 Hong Kong reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 10,928 Tandem Diabetes Care shares in Q4 2024, an estimated $463K.
  • Point72 Hong Kong first reported a position in Tandem Diabetes Care in Q3 2016 and held it in 14 quarters.
  • Point72 Hong Kong's Tandem Diabetes Care position peaked at $1.4M in Q4 2020.
  • 316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Point72 Hong Kong's 13F filing for Q4 2024, filed 14 Feb 2025.